Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutro-penic cancer patients

By Ibrahim Ezzeldin   Al-Mulhim Fatma  

Medical Oncology, Vol. 14, Iss. 1, 1997-03 ,pp. : 47-51

Humana Press, Inc

Access to resources Recommend Favorite

Granulocyte-macrophage Colony-stimulating Factor Improves Immunological Parameters in Patients with Refractory Solid Tumours Receiving Second-line Chemotherapy: Correlation with Clinical Responses

By Baxevanis C.N.   Tsavaris N.B.   Papadhimitriou S.I.   Zarkadis I.K.   Papadopoulos N.G.   Bastounis E.A.   Papamichail M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1202-1208

Elsevier

Access to resources Recommend Favorite

Phase trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 865-868

Science Publishers

Access to resources Recommend Favorite

Recombinant Human Granulocyte-Macrophage Colony-stimulating Factor After Combined Chemotherapy in High-grade Non-Hodgkin's Lymphoma--a Randomised Pilot Study

By Bergmann L.   Karakas T.   Knuth A.   Lautenschlager G.   Mitrou P.S.   Hoelzer D.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2164-2168

Elsevier

Access to resources Recommend Favorite

Use of granulocyte-macrophage colony stimulating factor in the treatment of prolonged haematopoietic dysfunction after chemotherapy alone or chemotherapy plus bone marrow transplantation

By Dierdorf Rainier   Kreuter Ulrich   Jones Thomas  

Medical Oncology, Vol. 14, Iss. 2, 1997-06 ,pp. : 91-98

Humana Press, Inc

Access to resources Recommend Favorite